Location: Palo Alto, CA
CIK: 0001744967 · Show all filings
Period: Q4 2025 (← Previous) (Next →)
Filing Date: Feb 17, 2026
Total Value: $969M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SRRK | SCHOLAR ROCK HLDG CORP | 6,897,652 | $304M | 31.3% | $14.61 | +156.7% | COM | 80706P103 |
| MLYS | MINERALYS THERAPEUTICS INC | 5,871,018 | $213M | 22.0% | $16.38 | +144.9% | COM | 603170101 |
| KLRS | KALARIS THERAPEUTICS INC | 12,948,081 | $109M | 11.3% | $9.40 | -32.0% | COM | 482929106 |
| SEPN | SEPTERNA INC | 3,149,128 | $87.8M | 9.1% | $22.17 | +7.7% | COM | 81734D104 |
| ALMS | ALUMIS INC | 5,756,984 | $56.19M | 5.8% | $9.30 | -24.9% | COM | 022307102 |
| NGNE | NEUROGENE INC | 1,717,127 | $35.37M | 3.6% | $20.31 | +22.6% | COM | 64135M105 |
| IVA | INVENTIVA SA | 5,194,805 | $24.16M | 2.5% | $4.65 | — | ADS | 46124U107 |
| GOSS | GOSSAMER BIO INC | 7,222,559 | $22.39M | 2.3% | $1.41 | +102.4% | COM | 38341P102 |
| UPB | UPSTREAM BIO INC | 736,047 | $19.98M | 2.1% | $22.33 | +11.5% | COM | 91678A107 |
| AQST | AQUESTIVE THERAPEUTICS INC | 2,500,000 | $16.15M | 1.7% | $4.32 | +44.1% | COM | 03843E104 |
| JBIO | JADE BIOSCIENCES INC | 968,798 | $14.95M | 1.5% | $23.56 | -50.2% | COM NEW | 008064206 |
| VTVT | VTV THERAPEUTICS INC | 298,496 | $11.94M | 1.2% | $14.92 | +85.9% | CL A NEW | 918385204 |
| RANI | RANI THERAPEUTICS HLDGS INC | 8,500,000 | $11.47M | 1.2% | $1.51 | 0.0% | COM CL A | 753018100 |
| PVLA | PALVELLA THERAPEUTICS INC NE | 104,817 | $10.97M | 1.1% | $15.71 | +443.1% | COM | 697947109 |
| ABVX | ABIVAX SA | 75,442 | $10.17M | 1.0% | $84.90 | — | SPONSORED ADS | 00370M103 |
| XFOR | X4 PHARMACEUTICALS INC | 1,960,000 | $7.84M | 0.8% | $3.63 | 0.0% | COM NEW | 98420X202 |
| NKTX | NKARTA INC | 3,507,666 | $6.489M | 0.7% | $21.30 | -90.6% | COM | 65487U108 |
| ACLX | ARCELLX INC | 60,873 | $3.969M | 0.4% | $16.49 | +383.8% | COMMON STOCK | 03940C100 |
| STRO | SUTRO BIOPHARMA INC | 204,503 | $2.366M | 0.2% | $9.49 | 0.0% | COM SHS | 869367201 |
| CTNM | CONTINEUM THERAPEUTICS INC | 72,245 | $826K | 0.1% | $16.10 | -29.2% | CL A | 21217B100 |
| — | NUVATION BIO INC | 124,119 | $40,959 | 0.0% | $0.28 | — | *W EXP 02/10/202 | 67080N119 |